BioLineRx Announces Regulatory Submission for Novel Stem Cell Mobilization Treatment

The phase 1 Trial of BKT-140/BL-8040 expected to begin in Q2 2014; top-line results expected in H2 2014

BKT-140/BL-8040 is also in Phase 2 for AML; top-line results expected in H2 2014

Read More